DFPG Investments’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$317K Sell
9,408
-848
-8% -$31.5K 0.02% 507
2023
Q3
$364K Sell
10,256
-1,477
-13% -$72.1K 0.03% 430
2023
Q2
$627K Buy
11,733
+1,392
+13% +$64.2K 0.06% 330
2023
Q1
$429K Buy
10,341
+1,616
+19% +$67.1K 0.05% 368
2022
Q4
$366K Buy
+8,725
New +$364K 0.06% 321

Other funds holding ATRC

DFPG Investments's ATRC Position: Q4 2023 in Review

DFPG Investments reduced its AtriCure (ATRC) stake by 8.3% in Q4 2023, selling an estimated $31.5K and leaving 9,408 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #507.

DFPG Investments first reported a position in ATRC in Q4 2022 and has held it in 5 quarters since. The position peaked at $627K in Q2 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • DFPG Investments held 9,408 shares of AtriCure worth $317K as of Q4 2023.
  • DFPG Investments sold 848 AtriCure shares in Q4 2023, an estimated $31.5K.
  • AtriCure made up 0.02% of DFPG Investments's portfolio in Q4 2023, its #507 holding.
  • DFPG Investments first reported a position in AtriCure in Q4 2022 and has held it in 5 quarters since.
  • DFPG Investments's AtriCure position peaked at $627K in Q2 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.